Teresa Mccarthy Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 months ago
Teresa Mccarthy has an estimated net worth of at least $14.6 million*, as of Oct. 29, 2025. They own shares of RNA stock. They have sold 196,864 shares of RNA stock since 2021, for an estimated $7.8 million.
Teresa Mccarthy $RNA SEC Form 4 Insider Trading
Teresa Mccarthy has filed a total of 17 insider trades in $RNA since 2021. Their most recent trade was a sale of 1,453 shares, made on Jan 21, 2026. Their largest trade was a sale of 25,000 shares, made on Dec 16, 2024. We estimate that they now own shares of $RNA, worth an estimated $6.8 million.
Insider Trading at $RNA
There have been a total of 160 insider trades reported at $RNA since 2021, with 800,000 shares purchased and 2.9 million shares sold. The most active insider traders in $RNA stock have been Sarah Boyce, Michael F Maclean, and Teresa Mccarthy. The most recent trade was a sale of 2,878 shares reported by Steven George Hughes (Chief Medical Officer), made on Jan 21, 2026.
History of Insider Stock Trades by Teresa Mccarthy
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
RNA
|
Sale | 1,453 | Jan 21, 2026 | Jan. 23, 2026, 6:33 p.m. |
RNA
|
Sale | 1,476 | Jan 21, 2026 | Jan. 23, 2026, 6:33 p.m. |
RNA
|
Sale | 1,965 | Jan 07, 2026 | Jan. 9, 2026, 6:13 p.m. |
RNA
|
Sale | 20,000 | Oct 15, 2025 | Oct. 17, 2025, 4:27 p.m. |
RNA
|
Sale | 15,000 | Sep 15, 2025 | Sept. 17, 2025, 4:03 p.m. |
RNA
|
Sale | 10,000 | Aug 15, 2025 | Aug. 15, 2025, 5:50 p.m. |
RNA
|
Sale | 7,778 | Mar 20, 2025 | March 21, 2025, 6:36 p.m. |
RNA
|
Sale | 1,738 | Jan 21, 2025 | Jan. 23, 2025, 9:14 p.m. |
RNA
|
Sale | 1,221 | Jan 21, 2025 | Jan. 23, 2025, 9:14 p.m. |
RNA
|
Sale | 11,151 | Dec 18, 2024 | Dec. 19, 2024, 7:15 p.m. |
RNA
|
Sale | 25,000 | Dec 16, 2024 | Dec. 18, 2024, 5:46 p.m. |
RNA
|
Sale | 25,000 | Nov 18, 2024 | Nov. 20, 2024, 7:10 p.m. |
RNA
|
Sale | 25,000 | Oct 16, 2024 | Oct. 17, 2024, 4:20 p.m. |
RNA
|
Sale | 13,153 | Sep 23, 2024 | Sept. 23, 2024, 9:06 p.m. |
RNA
|
Sale | 25,000 | Sep 11, 2024 | Sept. 13, 2024, 4:17 p.m. |
RNA
|
Sale | 9,864 | Jun 18, 2024 | June 20, 2024, 6:49 p.m. |
RNA
|
Sale | 2,065 | Jan 22, 2024 | Jan. 23, 2024, 4:11 p.m. |
$RNA Executives and Stock Owners with Insider Trades
-
Sarah Boyce, President and CEO
-
Michael F Maclean, Chief Financial Officer
-
Teresa Mccarthy, Chief Human Resources Officer
-
Steven George Hughes, Chief Medical Officer
-
Arthur A Levin, Chief Scientific Officer
-
Kathleen P. Gallagher, Chief Program Officer
-
W. Michael Flanagan, CSTO
-
W. Michael Flanagan, Chief Scientific Officer
-
Eric Mosbrooker, Chief Commercial Officer
-
John B Moriarty, Chief Legal Officer
-
Charles Iii Calderaro, Chief Technical Officer
-
Roderick Wong, MP and CIO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.